Rezultati - Lars Bastholt

Refine Results
  1. 1
    2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer

    2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer od Martin Schlumberger, Lars Bastholt, Henning Dralle, Barbara Jarząb, Furio Pacini, Johannes W. A. Smit

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab

    Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab od Anders H. Kverneland, Christian Enevold, Marco Donia, Lars Bastholt, Inge Marie Svane, Claus Henrik Nielsen

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

    Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model od Heinz Schmidt, Lars Bastholt, Poul Geertsen, Ib Jarle Christensen, S. Larsen, Julie Gehl, Hans von der Maase

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma

    PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma od Eva Ellebæk, Shawez Khan, Lars Bastholt, Henrik Schmidt, Charlotte Aaquist Haslund, Marco Donia, Inge Marie Svane

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Surgery and radiotherapy in the treatment of cutaneous melanoma

    Surgery and radiotherapy in the treatment of cutaneous melanoma od Alessandro Testori, Piotr Rutkowski, Jerry Marsden, Lars Bastholt, Vanna Chiarion‐Sileni, A. Hauschild, Alexander M.M. Eggermont

    Izdano 2009
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    The Feasibility of High Dose Iodine 131 Treatment as an Alternative to Surgery in Patients with a Very Large Goiter: Effect on Thyroid Function and Size and Pulmonary Function*

    The Feasibility of High Dose Iodine 131 Treatment as an Alternative to Surgery in Patients with a Very Large Goiter: Effect on Thyroid Function and Size and Pulmonary Function* od Steen Joop Bonnema, Henrik Bertelsen, Jesper Mortensen, P. B. Andersen, Dorthe U. Knudsen, Lars Bastholt, Laszlo Hegedüs

    Izdano 1999
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized Trial

    Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized... od Steen Joop Bonnema, Viveque Egsgaard Nielsen, Henrik Boel-Jørgensen, Peter Grupe, P. B. Andersen, Lars Bastholt, László Hegedüs

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma

    Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma od John M. Kirkwood, Lars Bastholt, Caroline Robert, Jeff Sosman, James Larkin, Peter Hersey, Mark R. Middleton, Mireille Cantarini, Victoria Zazulina, Karin Kemsley, Reinhard Dummer

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Small molecules and targeted therapies in distant metastatic disease

    Small molecules and targeted therapies in distant metastatic disease od Peter Hersey, Lars Bastholt, Vanna Chiarion‐Sileni, Gabriela Cinat, Reinhard Dummer, Alexander M.M. Eggermont, Enrique Espinosa, Axel Hauschild, Ian Quirt, Caroline Robert, Dirk Schadendorf

    Izdano 2009
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients

    The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients od Eva Ellebæk, Inge Marie Svane, Henrik Schmidt, Charlotte Aaquist Haslund, Marco Donia, Lise Hoejberg, Christina H. Ruhlmann, Louise Mahncke Guldbrandt, Ulrich Heide Køhler, Lars Bastholt

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer

    Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer od Lars Bastholt, Michael C. Kreißl, Dagmar Führer, Ana Luiza Maia, Laura D. Locati, Léa Maria Zanini Maciel, Yi Wu, Kevin N. Heller, Alan Webster, Rossella Elisei

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

    Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial od Michael C. Kreißl, Lars Bastholt, Rossella Elisei, Robert I. Haddad, Ole Hauch, Barbara Jarząb, Bruce Robinson, Raffaella Colzani, Meredith C. Foster, R. J. Weiss, Martin Schlumberger

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma od Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Immunotherapy of distant metastatic disease

    Immunotherapy of distant metastatic disease od Dirk Schadendorf, Salvador Martín‐Algarra, Lars Bastholt, Gabriela Cinat, Brigitte Dréno, Alexander M.M. Eggermont, Enrique Espinosa, Jun Guo, A. Hauschild, Teresa M. Petrella, Jacob Schachter, Peter Hersey

    Izdano 2009
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

    Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. od Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

    Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer od Steven I. Sherman, Lori J. Wirth, Jean-Pierre Droz, Michael Hofmann, Lars Bastholt, Renato Martins, Lisa Licitra, Michael Eschenberg, Yu-Nien Sun, Todd Juan, Daniel E. Stepan, Martin Schlumberger

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

    Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma od Kalijn F. Bol, Eva Ellebæk, Lise Hoejberg, Mette Bagger, Mathilde Skaarup Larsen, Tobias Wirenfeldt Klausen, Ulrich Heide Køhler, Henrik Schmidt, Lars Bastholt, Jens Folke Kiilgaard, Marco Donia, Inge Marie Svane

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

    Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline od Alexander Stratigos, Claus Garbe, Célèste Lebbé, Josep Malvehy, V. del Mármol, Hubert Pehamberger, Ketty Peris, Jürgen C. Becker, Iris Zalaudek, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Jean‐Jacques Grob

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer

    Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer od Martin Schlumberger, Rossella Elisei, Lars Bastholt, Lori J. Wirth, Renato Martins, Laura D. Locati, Barbara Jarząb, Furio Pacini, Chantal Daumerie, Jean-Pierre Droz, Michael Eschenberg, Yu-Nien Sun, Todd Juan, Daniel E. Stepan, Steven I. Sherman

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021

    Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021 od Neel Maria Helvind, Marie Brinch-Møller Weitemeyer, Annette H. Chakera, Helle Westergren Hendel, Eva Ellebæk, Inge Marie Svane, Mette Wanscher Kjærskov, Sophie Bojesen, Helle Skyum, Søren Kjær Petersen, Lars Bastholt, Christoffer Johansen, Pernille Envold Bidstrup, Lisbet Rosenkrantz Hölmich

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: